If accepted, the road-map would be implemented in 2014 and put local pharmaceutical manufacturers in a position to sustain a consistent manufacture of quality and safe medicines in Ghana and also for export.
úIt will also increase the capacity of our local pharmaceutical industries, create more jobs for Ghanaians, reduce the countryôs imports of medicines to further reduce loss of foreign exchange and improve the quality of accessible and affordable medicines,Ě Dr Stephen Opuni said.
He said this when he met members of the Pharmaceutical Manufacturers Association of Ghana (PMAG) to introduce the road-map to them.
The road map was necessitated by the African Union (AU) which chose Ghana as a model country to push the agenda of supporting and promoting local manufacturers in Africa to reduce if not eliminate the importation of pharmaceutical products characterised with the influx of fake medicinal products on the African market.
Ghana, he said, was selected based on the stringent regulatory oversight provided by the FDA, after WHOôs recent current Good Manufacturing Practices (GMP) inspections conducted in the manufacturing industries in which were deficiencies.
úThese deficiencies include lack of adequate technical and human resources with the requisite qualification and experience in pharmaceutical operations coupled with manufacturing from non-GMP compliant facilities,Ě he said..
Dr Opuni appealed to local pharmaceutical industries to take advantage of the AU steps as well as the roadmap and employ qualified staff who would benefit from the FDAôs newly formed Industrial Support Services Department as well as the Centre for Pharmaceutical Advancement and Training, set-up by the United States Pharmacopoeia.
He assured the manufacturers of FDAôs readiness to work with all local industries to embrace the change under the continuing stringent regulatory oversight.
úThe road-map is not to collapse their businesses but to help you improve in your activities and breakthrough the African marketĚ, he added.
Dr Michael Agyekum Addo, Chief Executive Officer of KAMA Group Ghana Limited on behalf of the members of the local pharmaceutical manufacturers appealed to FDA to intervene on their behalf at the ECOWAS level to enable members penetrate the Anglophone market.
He commended FDA for coming up with a strategy to help the local industries perform better.